This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: King's College London. Active years: 2018-2022.
Company Filing History:
Years Active: 2018-2022
Title: Mark Trevor Mills: Innovator in Therapeutic Compounds
Introduction
Mark Trevor Mills is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of therapeutic compounds, holding a total of 4 patents. His work focuses on innovative solutions that address critical medical challenges.
Latest Patents
One of Mills' latest patents involves bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARβ) agonists. This invention pertains to the development of compounds that selectively activate RARβ, which plays a crucial role in promoting neurite development, outgrowth, and regeneration. These compounds are particularly relevant in the treatment of neurological injuries, such as spinal cord injuries, and have potential applications in various therapeutic compositions.
Career Highlights
Mark Trevor Mills is affiliated with King's College London, where he continues to advance his research in therapeutic compounds. His innovative work has positioned him as a key figure in the field, contributing to the understanding and treatment of conditions mediated by RARβ.
Collaborations
Mills collaborates with esteemed colleagues, including Alan D Borthwick and Jane Theresa Brown. These partnerships enhance the research and development of his innovative therapeutic solutions.
Conclusion
Mark Trevor Mills exemplifies the spirit of innovation in the field of therapeutic compounds. His contributions through patents and collaborations continue to pave the way for advancements in medical treatments.